FDA Recalls Fosaprepitant Injection Due to Sterility Assurance Failure
BE Pharmaceuticals recalls Fosaprepitant for Injection nationwide due to failed aseptic process validation. The 22,176 vials from lot #13D012AA may lack sterility assurance.
- Product
- FOSAPREPITANT — FOSAPREPITANT (FOSAPREPITANT)
- Category
- Drug
- Distribution
- Distributed nationwide